Clinical trial

Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).

NCT02695004

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-02-01

PhasePHASE1

Study timeline

Study start (unknown)2016-02-01Date precision: month

Registry last updated2020-04-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

DKF-310DRUG

PlaceboDRUG

Sponsors & collaborators

Dongkook Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02695004 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.